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Objectives: 18F-ﬂuorodeoxyglucose  (FDG)  positron  emission  tomography  (PET)/computed  tomography
(CT)  is a useful  tool  for evaluating  inﬂammation.  Because,  myocardial-FDG  uptake  occurs  with  diverse
physiology,  it  should  be suppressed  during  evaluation  of  myocardial  inﬂammation  by FDG-PET/CT.
Diets  inducing  fat-based  metabolism,  such  as a  low-carbohydrate,  high-fat  diet  (LCHF),  are  used  in
uptake-suppression  protocols.  However,  a complete  suppression  of  myocardial-FDG  uptake  has  not  been
established.  Hence,  we  assessed  the  efﬁcacy  of 24-h  carbohydrate  restriction  along  with  an  LCHF  diet  com-
pared  to  that  of  the  conventional  protocol  in  suppressing  myocardial-FDG  uptake  and  also  compared  fat
and  glucose  metabolism  between  these  protocols.
Methods: Fourteen  healthy  volunteers  agreed  to undergo  >24-h  carbohydrate  restriction  (glucose,  <10  g)
and  drank  an  LCHF  beverage  an  hour  before  FDG  administration.  A scan  performed  under conventional
fasting  protocol  served  as  the control.  The  maximal  standardized  uptake  values  (SUVmax)  of the  left ven-
tricular  (LV) myocardium,  and left atrium  lumen  (blood  pool),  liver,  and  lung  ﬁelds  as  background,  were
measured.  Blood  sugar,  free  fatty  acids  (FFAs),  insulin,  and triglyceride  concentrations  were measured
just  before  FDG  injection  and  compared  between  the  2 protocols.
Results: Global  LV  myocardial  uptake  was  signiﬁcantly  lower  with  the  diet-preparation  protocol  (SUVmax
1.31  [1.15–1.49]  vs. 2.98 [1.76–6.43],  p =  0.001).  Target-to-background  ratios  [myocardium-to-blood  ratio
(MBR),  myocardium-to-lung  ratio (MLR),  and  myocardium-to-liver  ratio  (MLvR)]  were  also  signiﬁcantly
lower  with  the diet-preparation  protocol  [MBR:  0.75  (0.68–0.84)  vs. 1.63  (0.98–4.09),  p  < 0.001;  MLR:  1.87
(1.53–2.47)  vs. 4.54  (2.53–12.78),  p  =  0.004;  MLvR:  0.48 (0.44–0.56)  vs. 1.11 (0.63–2.32),  p =  0.002].  Only
insulin  levels  were  signiﬁcantly  different  between  the  subjects  in each  protocol  group  (11.3  [6.2–15.1]
vs.  3.9  [2.9–6.2]).
Conclusion:  Carbohydrate  restriction  together  with  an  LCHF  supplement  administered  1 h  before  FDG
myoc




A major obstacle in diagnosing myocardial inﬂammation
sing 18F-ﬂuorodeoxyglucose (FDG) positron emission tomogra-
hy (PET)/computed tomography (CT) is the high physiological
ccumulation of FDG in the myocardium, which interferes with
he recognition of abnormal FDG uptake [1,2]. Suppression of
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this unfavorable uptake might improve the clinical usefulness of
FDG-PET/CT for identifying cardiac inﬂammatory diseases such as
cardiac sarcoidosis [3–5]. Several investigators have reported that a
high blood level of free fatty acids (FFAs) decreases myocardial glu-
cose uptake [6,7]. The administration of heparin, which increases
blood FFAs, has been commonly used before FDG injection to
suppress myocardial-FDG uptake [4]. Another method used to sup-
press myocardial FDG uptake is to administer a low-carbohydrate,
high-fat (LCHF) dietary supplement before the procedure. Such a
supplement is thought to elevate FFA levels in the blood and to
induce fat-dominated metabolism, which decreases FDG accumu-
lation in the myocardium. Reducing FDG accumulation through a
dietary approach has the advantages of being non-invasive and low
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ost [8,9]. Cheng et al. reported that carbohydrate restriction alone,
ithout high-fat loading, also effectively reduced myocardial-FDG
ptake [10]. To clearly identify pathological uptake as such, the
ormal physiological uptake should be abolished. However, the
hysiological uptake of FDG has not been sufﬁciently suppressed
y any of the previously reported protocols [8–10]. Therefore, an
ffective method of suppressing FDG uptake is still sought. The efﬁ-
acy of a long fasting period has proven controversial [11–13]. The
ptimal duration of an LCHF diet for suppressing FDG uptake is
lso unclear [8–10]. In our pilot study, we found that eating an
vening meal with a high fat content (approximately >60 g) or a
ow carbohydrate content the day before the test did not abso-
utely suppress FDG myocardial uptake. Based on these ﬁndings,
e inferred that a 24-h period of carbohydrate restriction and
elatively high fat intake would lead to stable and signiﬁcant sup-
ression of myocardial-FDG uptake. The purpose of the present
tudy was to assess the efﬁcacy a 24-h period of carbohydrate
estriction along with an LCHF diet in suppressing myocardial FDG
ptake compared to that of the conventional protocol and to com-
are fat and glucose metabolism between these protocols.
ethods
ubjects
This  study was designed in accordance with the Declaration of
elsinki and was approved by the ethics review board of our institu-
ion. Informed consent was obtained from all volunteers. Although
6 healthy volunteers were candidates for this study, 2 of them
1 man  and 1 woman) who could not adhere to the diet instructions
ere excluded. The remaining 14 subjects (6 men  and 8 women,
1.1 ± 14.6 years of age; range, 29–68 years) were included. None
f the subjects had acute inﬂammatory disease (e.g. cholecystitis or
ancreatitis), solid food dysphasia, diabetes mellitus, or abnormal
lectrocardiographic ﬁndings. All subjects had serum triglycerides
elow 600 mg/dL.
DG-PET/CT scanning with the modiﬁed diet and conventional
rotocols
All  subjects underwent FDG-PET/CT according to the modiﬁed
nd conventional protocols. As a control in the conventional
ig. 1. The modiﬁed diet protocols for 18F-ﬂuorodeoxyglucose (FDG) positron emission t
orning  or at night. Each protocol used carbohydrate restriction for more than 24 h. LCHdiology 62 (2013) 314–319 315
protocol, there was a fasting period of at least 6 h before FDG
administration (mean, 8.6 h; range, 6.0–19.5 h). The modiﬁed
protocol involved a carbohydrate restriction period of at least
24 h and an LCHF dietary supplement. “Carbohydrate restriction”
was deﬁned as follows: Except for the meal prescribed by us,
carbohydrate intake was strictly prohibited for more than 24 h
(Fig. 1). Only water and sugar-free tea were allowed. The subjects
ate prescribed meals that contained less than 10 g of glucose,
more than 35 g of fat, and had approximately 550–750 kcal. The
prescribed meals contained less fat than those of past reports, as
very high fat diets caused a heavy feeling in the stomach, and high
fat content was  unfavorable for clinical use. In addition, results of a
previous report and our pilot study indicated that a solely high-fat
diet did not effectively reduce myocardial-FDG uptake [10]. Our
subjects also drank 150 mL  of a low carbohydrate (1 g of glucose),
high fat (9 g of fat) beverage (Atkins Advantage Shake, Atkins
Nutritionals, Ronkonkoma, NY, USA) 1 h before the administration
of FDG to cause serum FFA elevation. Immediately after the intake
of 500 mL  of water, PET and CT images were acquired using a
PET/CT scanner with 16-slice CT (GEMINI TF 16, Philips Healthcare,
Best7, The Netherlands). Under normal breathing, CT images were
obtained from the head to the mid-thigh level. PET images were
obtained 60 min  after the injection of a 4 MBq/kg dose of FDG
and over 3 min  per position. To reduce radiation exposure, we
used half the FDG dose used in the modiﬁed diet protocol for
the conventional fasting protocol. The images were iteratively
reconstructed with CT-based attenuation correction. The interval
between the 2 PET scan studies was 30.0 ± 23.3 days. During
this interval, no signiﬁcant body weight change was  observed
in subjects except one woman who  experienced a very minor
reduction (0.04 kg/day); no cardiac or other organ events occurred.
Data analysis
All  PET/CT data were analyzed on a computer workstation.
Two-dimensional regions of interest (ROI) were drawn on the
transaxial slices of PET images to measure the standardized uptake
value (SUV) of the entire left ventricular myocardium; SUV = (peak
kBq/mL in ROI)/(injected activity/g body weight). Myocardial-FDG
uptake was  expressed as the maximal SUV (SUVmax). To calcu-
late the target-to-background ratio (TBR), ROIs were drawn in
omography/computed tomography scanning. FDG injection time was either in the
F, low-carbohydrate, high-fat.
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he left atrium lumen and lung ﬁelds as background. The left
entricular myocardium-to-blood ratio (MBR = [SUVmax in the left
entricular myocardium]/[SUVmax in the left atrium lumen]), left
entricular myocardium-to-lung ratio (MLR = [SUVmax in the left
entricular myocardium]/[SUVmax in the lung ﬁelds]), and left
entricular myocardium-to-liver ratio (MLvR = [SUVmax in the left
entricular myocardium]/[SUVmax in the left lobe of liver]) were
alculated. The SUVmax in the left ventricular myocardium, MBR,
LR, and MLvR obtained using the conventional and modiﬁed diet
rotocols were compared. The visual uptake scale referenced by
illiams and Kolodny [8] was also used to estimate the effect of
he diet preparation on FDG uptake. FDG-PET/CT scans from 14 sub-
ects prepared by fasting and the modiﬁed protocol were divided
nto 4 groups based on qualitative visual estimation of FDG myocar-
ial uptake: 0, homogeneously minimal; 1, mostly minimal or mild
ptake; 2, mostly intense or moderate uptake; and 3, homoge-
eously intense (Fig. 2). For the visual analysis of PET, maximum
ntensity projection (MIP) image and transaxial data from slices
f myocardium were used. First, cases that were clearly identi-
ed as grade 1–3 were chosen using MIP  images. Then, for the
emaining cases, transaxial data for the entire left ventricular wall
ig. 2. Four-grade visual analog scale: 0, homogeneously minimal uptake; 1, mostly
inimal or mild uptake; 2, mostly intense or moderate uptake; and 3, homoge-
eously  intense uptake.
ig. 3. Maximal standardized uptake value (SUVmax) of the left ventricular (LV) myocard
UVmax/left atrial lumen SUVmax; MLR, myocardium-to-lung ratio = LV wall SUVmax/lung ar
obe of liver SUVmax) are displayed. All of these parameters were signiﬁcantly lower withdiology 62 (2013) 314–319
were checked. Cases in which free wall uptake or papillary muscle
uptake were detected were designated as grade 1. In addition, the
concentrations of blood sugar (BS), FFAs, insulin, and triglycerides
(TG) just before FDG injection were compared between the two
protocols.
Statistical analysis
All  statistical analyses were performed using Excel 2007 with
the add-in software Statcel 2. Continuous variables for categorical
data were expressed as mean ± SD. Wilcoxon signed-rank test was
used for SUV data and blood exam analyses. A 2-tailed probability
value of less than 0.05 was  considered to be statistically signiﬁ-
cant. Data were expressed as median values (25th–75th). For visual
analog scale analysis, McNemar’s test was performed (p < 0.05 was
signiﬁcant).
Results
The parameters for myocardial-FDG uptake are shown in Fig. 3.
SUVmax of the left ventricular myocardium was signiﬁcantly lower
with the modiﬁed protocol than with the conventional protocol
(SUVmax, 1.31 [1.15–1.49] vs. 2.98 [1.76–6.43]; p = 0.001). MBR,
MLR, and MLvR were also signiﬁcantly lower with the modiﬁed
protocol (MBR, 0.75 [0.68–0.84] vs. 1.63 [0.98–4.09], p < 0.001;
MLR, 1.87 [1.53–2.47] vs. 4.54 [2.53–12.78], p = 0.004; MLvR,
0.48 [0.44–0.56] vs. 1.11 [0.63–2.32], p = 0.002). The comparison
made using the visual analog scale is shown in Table 1. Visual
analog scale analysis indicated that the modiﬁed diet protocol
resulted in signiﬁcant suppression of FDG uptake (p = 0.041). For the
modiﬁed protocol, all residual FDG uptake occurred in papillary
muscles (Fig. 4, Table 2). There were no signiﬁcant differences
between the 2 protocols with respect to the BS, FAAs, and TG lev-
els just before FDG injection (Table 1). It is interesting that only
the insulin level was  higher in the modiﬁed protocol than in the
conventional protocol. Fig. 5 shows the results from 2 subjects
regarding insulin levels and FDG uptake.
ium and target-to-background ratios (MBR, myocardium-to-blood ratio = LV wall
ound left ventricular SUVmax; MLvR, myocardium-to-liver ratio = LV wall SUVmax/left
 the modiﬁed protocol than with the conventional protocol.
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Table  1
Myocardial-18F-ﬂuorodeoxyglucose (FDG) uptake after conventional or modiﬁed
dietary  protocol. All data are expressed as number (%). Even in qualitative visual
analysis,  the modiﬁed protocol resulted in a signiﬁcant reduction in myocardial-FDG
uptake  (p = 0.041).
Visual analog scale Conventional protocol Modiﬁed protocol
0 4 (28.6%) 10 (71.4%)
1 2 (14.3%) 4* (28.6%)
2 7 (50.0%) 0 (0%)
3 1 (7.1%) 0 (0%)
Modiﬁed  protocol
Uptake (−) Uptake (+)
Conventional protocol
Uptake  (−) 4 0
Uptake (+) 6 4
Visual analog scale 0 = uptake (−); 1, 2, 3 = uptake (+).

























Laboratory data for subjects using conventional and the modiﬁed protocols. The
only variable with a signiﬁcant difference between the protocols was insulin level,
which was  signiﬁcantly higher in subjects using the modiﬁed protocol than in those
using the conventional protocol, regardless of marked suppression of myocardial
18F-ﬂuorodeoxyglucose uptake.
Fasting protocol Modiﬁed protocol p value
Free fatty acids
(mequiv./L)
0.80  (0.62–0.90) 0.61 (0.51–0.69) 0.221
Insulin (U/mL) 3.9 (2.9–6.2) 11.3 (6.2–15.1) 0.019*
Blood sugar (mg/dL) 100 (91–105) 102 (95–107) 0.233
inﬂammatory activity in these muscles.
F
s
s* In 4 subjects, FDG uptake was in papillary muscles and not in the free left
entricular  wall.
iscussion
In this study, we demonstrated that our modiﬁed diet proto-
ol using carbohydrate restriction over a 24-h period along with
CHF support signiﬁcantly suppressed myocardial-FDG uptake
ompared to the conventional protocol. Using the modiﬁed diet
rotocol, the level of FFAs was not signiﬁcantly higher than that
chieved using the conventional protocol. These data contrast
hose of a previous study indicating that high FFA concentrations
nhibited myocardial glucose utilization. There were no signiﬁcant
ifferences in BS or TG level at the time of FDG injection between
he 2 protocols. Only the insulin level was signiﬁcantly higher in
ubjects using the modiﬁed protocol.
Williams and Kolodny [8] and Harisankar et al. [9] reported
hat with the diet suppression protocol, myocardial SUVmax was
.9 ± 3.6 (mean ± SD), and 3.29 (mean), respectively. Cheng et al.
10] found that the myocardial SUVmax was 3.3 ± 2.7 (mean ± SD)
ith carbohydrate restriction and 5.5 ± 4.2 (not signiﬁcantly sup-
ressed compared to fasting) with the LCHF preparation. In contrast
o these previous ﬁndings, signiﬁcant suppression of myocar-
ial uptake [myocardium SUVmax, 1.31 (1.15–1.49); median
25th–75th)] was achieved using our modiﬁed protocol. Myocar-
ial physiological FDG uptake closely correlated with the period of
arbohydrate restriction. Although the effect of “long fasting” on
yocardial-FDG uptake has been controversial [11–13], the 24-h
ig. 4. Case presentation. Axial image of plain computed tomography (CT) (left) and 18F-
ubject  who  followed the modiﬁed protocol. Residual papillary muscle FDG uptake was ob
trongly  suppressed (white arrow heads). Laboratory data for the subject: triglycerides, 62Triglycerides (mg/dL) 94 (82–115) 75 (67–99) 0.198
All data are expressed as median values (25th–75th).
carbohydrate restriction used in this study resulted in signiﬁcant
myocardial suppression. Cardiac myocytes utilize glucose as an
energy source via insulin-sensitive glucose transporters (GLUT4)
[14]. Expression of GLUT4 genes is known to be suppressed via
intracellular mediators activated by a high concentration of FFAs
[15,16]. Therefore, it seems paradoxical that there were no signif-
icant differences in FAA concentrations in the present study. The
results of this study thus indicate that there are complex metabolic
interactions between fat, glucose, and other metabolic substrates in
the myocardium; other organs such as the liver might be involved
in myocardial-FDG uptake [17].
Papillary muscle FDG uptake occurred in every volunteer with
residual FDG uptake, a phenomenon that has been reported in other
trials [10]. One of the causes of this residual uptake is thought to
be mechanical stress. A previous fasting preparation study of the
distribution of FDG uptake in patients with complete left bundle
branch block (CLBBB) showed that low mechanical stress areas,
such as the interventricular septum during the systolic phase,
exhibited lower uptake than did the rest of the left ventricular
myocardium [18]. This report also showed homogeneous myocar-
dial glucose metabolism under synchronous wall motion of the left
ventricular myocardium after resynchronization therapy [18]. The
papillary muscles are located at the most distal site in terms of coro-
nary blood ﬂow, and this anatomical feature might cause residual
FDG uptake by the papillary muscles. One clinicopathologic study
of autopsy cases has reported that cardiac sarcoidosis lesions often
affect the papillary muscles [19]. Therefore, when using this mod-
iﬁed diet protocol we  should be careful of overevaluation of theAs previously mentioned, cardiac myocytes utilize glucose as
an energy source via GLUT4 [14,15]. Because macrophages take
in glucose mainly via GLUT1 and GLUT3 [20], which are not
ﬂuorodeoxyglucose (FDG) positron emission tomography/CT fusion (right) from a
tained (white arrow). Physiological FDG uptake of the left ventricular free wall was
 mg/dL; free fatty acids, 0.73 mequiv./L; insulin, 0.4 U/mL; blood sugar, 95 mg/dL.
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Fig. 5. Case presentation. Case A: Laboratory data (Conventional/modiﬁed protocol): triglycerides (TG), 85/46 mg/dL; free fatty acids (FFAs), 0.78/0.67 mequiv./L; insulin,
































nyocardial suppression was  achieved using the modiﬁed diet protocol compared to t
8F-ﬂuorodeoxyglucose uptake using both protocols was seen, despite higher serum
nsulin-dependent, FDG uptake in cardiac inﬂammatory lesions is
ot expected to be reduced with the modiﬁed diet protocol. There-
ore, myocardial-FDG uptake (particularly with respect to stability
nd reproducibility) must be clearly controlled to be useful for the
ssessment of myocardial inﬂammation such as cardiac sarcoido-
is or pericardial inﬂammatory diseases [3–5,21,22]. We  emphasize
hat the modiﬁed protocol is ideal for evaluating myocardial inﬂam-
ation because of the signiﬁcant suppression of physiological FDG
ptake we observed in this study.
Insulin levels were signiﬁcantly higher with the modiﬁed proto-
ol than with the conventional protocol. This was probably due to
dministration of the Atkins beverage just before the FDG injection.
his ﬁnding is interesting because this elevation in serum insulin
id not affect the suppression of myocardial-FDG uptake. The bev-
rage contained only 1–2 g glucose, and the time interval between
dministration of the drink and FDG injection was short, thus hav-
ng a minimal effect on GLUT4. Temporal insulin resistance caused
y long-term diet might be another possible explanation for this
henomenon. This result leads to our presumption that a thresh-
ld glucose content of a meal or beverage exists with respect to
yocardial FDG suppression, but further examination is required.
here were no signiﬁcant differences in FFAs levels between two
rotocols. High-fat loading just an hour before the FDG injection
id not seem to directly elevate FFA levels, probably due to indi-
idual differences in digestion. Drinking an LCHF beverage before
DG injection might have variable results due to variations in indi-
idual metabolism. Therefore, we considered that drinking an LCHF
everage before the injection should be avoided. Free blood sugar
evels were within the normal range; therefore, it seems there was
o competitive restriction. the conventional protocol. Interestingly, in case B, complete abolition of myocardial-
lin levels and lower FFA concentrations.
Our study has several limitations. The small number of sub-
jects is a major limitation. However, the quantitative values,
including SUVmax, were very low with the modiﬁed protocol; we
can thus infer that the suppression of myocardial-FDG uptake
was signiﬁcant. Our subjects’ compliance with dietary instruc-
tions was based on self-reporting, which is another limitation. To
avoid mistakes concerning the dietary preparation, we directly
instructed all patients and they took meals prepared by the Nutri-
tion Department at our institution most of the time. Since the
duration of fasting varied among the subjects who  used the con-
ventional protocol, myocardial-FDG uptake values also varied. Yet
very low myocardial-FDG uptake was  observed with the modi-
ﬁed protocol in all the subjects, and the variation was  very low
compared to that of the conventional protocol. Thus, we con-
sider that signiﬁcant suppression of myocardial-FDG uptake can
be obtained using the modiﬁed protocol. In this study, cardiac
magnetic resonance imaging (MRI) and coronary CT angiography
were not performed. Although PET/CT results were not compared
with those of cardiac MRI  and coronary CT angiography, signif-
icant suppression of myocardial-FDG uptake indicated that the
subjects had no myocardial or coronary artery diseases. Healthy
volunteers were used in the present study; hence, we did not
include patients with conditions such as cardiac sarcoidosis or
cardiac failure. This was  a major limitation, and further examina-
tion is therefore necessary. We  did not examine the blood sample
data before consumption of the high-fat drink. In our pilot study,
FFA concentrations before and after consumption of the high-fat
drink were variable. Therefore, in this study, blood samples were
only taken just before the FDG injection. This timing seemed to
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ssess the blood conditions before consumption of the high-fat
rink.
onclusion
A modiﬁed protocol using long-term carbohydrate restriction
long with a LCHF diet drastically suppressed myocardial-FDG
ptake. This protocol has the potential to enhance the value of
DG-PET/CT for the evaluation of myocardial inﬂammation.
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